This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The launch of ChatGPT in November 2022 set off a generativeAI gold rush, with companies scrambling to adopt the technology and demonstrate innovation. Legacy chatbots, product recommendation engines, and several other useful tools may rely only on earlier forms of AI.
Qventus platform tries to address operational inefficiencies in both inpatient and outpatient settings using generativeAI, machine learning and behavioural science. Related reading: The Weeks Biggest Funding Rounds: Data Storage And Lots Of Biotech Illustration: Dom Guzman The round was led by Kleiner Perkins.
billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. Yet even amid the hottest period ever for AI funding , investment in AI-enabled health startups has remained below 2021 levels.
Gains go to states with heavily funded generativeAI startups There are, of course, many complex dynamics at play in determining why a particular state or metro area might see its startup investment fortunes rise or fall. However, in 2024 there was also a simple explanation for the funding pattern: generativeAI.
The new round is bigger than the $6 billion round Elon Musk ’s generativeAI startup, xAI , officially announced in May, which up to this point was the largest round raised this year. Pacific Fusion , $900M, energy: Another huge AI-related round. Poolside is just one of a handful of big deals recently in the AI coding space.
This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 The biotech sector’s comparatively strong showing comes as overall Series A dealmaking looks on track to come in a bit above last year’s totals.
Last month, xAI and Anthropic raised a combined $9 billion as AI funding remained red-hot. xAI , $5B, artificial intelligence: GenerativeAI startup xAI raised $5 billion in a round valuing it at $50 billion, The Wall Street Journal reported. and AI product development. Let’s take a look. billion in 2021.
Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. That makes it quite the month for startups looking to develop drugs and therapies for all that ails us. That sector saw seven of the rounds on this list. billion, per Crunchbase.
Of course, it was led by two well-known AI startups — including xAI , which had its second massive haul of cash in just six months. xAI , $5B, artificial intelligence: GenerativeAI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported.
San Francisco-based Writer locked up a $200 million Series C that values the enterprise-focused generativeAI platform at $1.9 The new cash will be used for the company’s quick-start AI applications and agents for workflows in healthcare, retail and financial services. “At
Stability AI , the venture-backed startup behind the text-to-image AI system Stable Diffusion, is funding a wide-ranging effort to apply AI to the frontiers of biotech. Stability AI’s ethically questionable decisions to date aside, machine learning in medicine is a minefield.
The retail industry has no shortage of cases on display where generativeAI has shown tangible benefits. They had ChatGPT write the script, and other gen AI tools to create a digital person who reads the script, a scalable process with at least one measurable benefit: speed. And software code is a language.”
Not surprisingly AI led the way — as it always seems to do — with a trio of a billion-or-more rounds. xAI , $6B, artificial intelligence: Elon Musk ’s generativeAI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generativeAI company in the world behind only competitor OpenAI.
SSI, co-founded by OpenAI ‘s former chief scientist Ilya Sutskever , is looking to develop safe artificial intelligence systems — something that has been in the news a lot recently as fears increase of AI tech being harmful to humans and society. The 3-month-old startup will look to add computing power and hire new talent.
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note.
Department of Energy ’s Milestone-Based Fusion Development Program. Pika , $80M, artificial intelligence: It never takes us long to get to an AI startup on this list. Pika is part of a growing group of startups building text-to-video AI software. tied) Twelve Labs , $50M, video: Yet another AI-related video startup.
Eight startups raised $100 million or more this week as a biotech and financial services company led the way. Yep, no huge AI raise. The startup is focused on developing therapeutics for the treatment of cardiovascular diseases. Scorpion Therapeutics , $150M, biotech: Yet another big biotech round.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. Rivos , $250M, semiconductor: Semiconductor startups are seeing big money, in part thanks to the explosion in generativeAI.
AI startup Safe Superintelligence ’s $1 billion round — for a startup that’s existed for only a few months — easily led the way. However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Candid is developing T-cell engager antibodies to treat inflammatory diseases.
The new round is bigger than the $6 billion round Elon Musk ’s generativeAI startup, xAI , officially announced in May — which was the largest round raised this year. Kailera Therapeutics , $400M, biotech: Biotech was even bigger this week than normal. Poolside has raised $626 million since being founded in May 2023.
xAI , $6B, artificial intelligence: Elon Musk ’s generativeAI startup, xAI, officially announced its long-awaited fundraise — making it the second-most-valuable generativeAI company in the world behind only competitor OpenAI. among others. among others. The xAI round had been rumored for months. just earlier this year.
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generativeAI markets.
Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. Scale AI , $1B, artificial intelligence: This week was like many — one topped with a big AI round. The startup will use the new cash to grow its user base and add developer tools.
While GenerativeAI is buzzy right now, what OpenAI, Microsoft and Google are doing may be only part of the story. Cortical combines synthetic biology and human neurons to develop what it claims is a class of AI, known as ‘Organoid Intelligence (OI)’.
Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical Applications Capgemini Nov 6, 2024 Facebook Linkedin The BioTechX event in Basel in October was a major gathering for biotech and pharma professionals. Last year, we were all about the potential of large language models and generativeAI.
The quintet that did raise big were from three of the usual sectors — biotech, energy and AI — however one was from a sector we don’t normally see — a vertical farming agtech startup. Fervo Energy, a geothermal developer, locked up a big $244 million round led by shale oil and gas firm Devon Energy Corp. billion Series B.
Andreessen co-led the Series B in AI voice software developer ElevenLabs with angel investors Nat Friedman and Daniel Gross. The firm also led the Series A in text-to-image generativeAI company Ideogram. Healthcare and AI lead The increase in funding at Series A and B in the U.S.
While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Celestial AI , $175M, semiconductors: Optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.
Investors certainly put their money everywhere, from biotech to productivity tools, but they didn’t shell out a lot. Pathalys Pharma , $105M, biotech: Raleigh, North Carolina-based Pathalys Pharma isn’t new to this list — it topped it early last year. The company specializes in late stages of developing treatments for kidney disease.
Formation Bio , $372M, biotech: Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. Founded in 2011, the company has raised $1.4 billion, per Crunchbase.
Big deals The largest startup funding round in April was a $1 billion deal to stealth startup Xaira Therapeutics for drug development using AI. Top sectors Biotech and healthcare was the leading sector by funding amount in April. However, larger private software companies are adapting quickly to this new technology cycle.
Converge Bio, a generativeAI platform for accelerated drug discovery and development, announced on Wednesday that it has raised $5.5 in Seed funding to speed up drug discovery and development with GenAI appeared first on OODAloop. million in Seed funding, led by TLV Partners.
The company is developing advanced small modular nuclear reactors for clean energy generation. Decagon , $65M, artificial intelligence: San Francisco-based company Decagon, a developer of AI customer support agents, raised a $65 million Series B led by Bain Capital Ventures. came from north of the border.
You had to raise more than $150 million to make the top 10 list this month — as investors put money into everything from defense tech to semiconductors to biotech. Groq , $640M, semiconductor: AI semiconductor and software startup Groq locked up a $640 million Series D round at a valuation of $2.8 billion Series E in late 2022.
While we saw enthusiasm for hot sectors like generativeAI, it was tempered by pullbacks in areas ranging from fintech to consumer products. In addition to AI, cleantech, biotech and next-generation manufacturing were among the areas where startups scored outsized rounds. billion Series C.
That included more than $200 million for a security company and lots of big biotech raises. NinjaOne , $232M, security : NinjaOne showed this week that not all big funding rounds go to generativeAI companies. Neurona Therapeutics , $120M, biotech: San Francisco-based Neurona Therapeutics was the big biotch winner this week.
It seems every time a large generativeAI company raises billions of dollars, one of the Big Tech pillars such as Nvidia , Microsoft or Google is leading the round. Large rounds it has led or co-led include those for biotech firm Santa Ana Bio , data observability startup Cribl , and AI legal tech firm Harvey.
However, M&A is not the only way to exit, and AI may be looking to help there too. It’s a good time to be an AI chip developer. Other companies that went public this year had strong AI ties — like biotech Tempus AI — or played up their AI connections strongly — like Reddit.
The company — a utility-scale solar and energy storage project development, ownership and operations platform — will use the new capital to grow its “high value project development pipeline.” Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generativeAI startup. billion in October 2022.
The company is developingAI-enhanced robots that it hopes will be able to perform dangerous jobs and alleviate labor shortages. The startup is a provider of Nvidia ’s latest GPUs, which are highly sought after by AIdevelopers. The round marks the largest by an AI startup this year, per Crunchbase data.
Four main categories for big AI fundraisers GenerativeAI remains the buzziest space for startup funding, so it’s not surprising to see the largest fundraising recipients fall in this category. Next up in the gen AI category are Anthropic , with $8.4 Editor’s note: The list includes Inflection AI.
The company continued hiring developers and marketers and raised the team by around 10%. Developed a SaaS-based white-label web3 platform that opens revenue streams and strengthens community engagement. Ahrefs claims to have become a $100 million company in annual revenue without venture capital. Incorporated in Delaware, USA.
It wasn’t surprising, for instance, to see that generativeAI has been a popular area for seed investors. AI-assisted diagnostics was one of the more popular focus areas. Others are turning to AI to better understand immune response. GenerativeAI Last but certainly not least on our list is generativeAI.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content